Catalent Institute: Non-invasive Macromolecule Delivery Consortium
Monday, November 17, 2014
10:45 AM - 11:10 AM
GH - Empire Ballroom I
The Non-invasive Macromolecule Delivery Consortium (NMDC) is committed to advancing the delivery of proteins, peptides, and vaccines by non-invasive or minimally invasive methods through collaborative efforts of industry and academia. Our objective is to improve compliance and therapeutic benefits for patients. We are providing opportunities for drug delivery experts to showcase new approaches in oral, pulmonary/intranasal, ocular, and transdermal delivery and focused on addressing the physical, physiologica,l and biochemical challenges that limit drug delivery through ongoing research. The presentation will focus on solving technical challenges.
Randy Mrsny, Chair of the Non-invasive Macromolecule Delivery Consortium, University of Bath
Terry Robinson, Executive Director, Catalent Applied Drug Delivery Institute
View the presentation slides as a PDF